Cargando…
Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms
In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065123/ https://www.ncbi.nlm.nih.gov/pubmed/24959399 http://dx.doi.org/10.3797/scipharm.1310-01 |
_version_ | 1782322035199836160 |
---|---|
author | Peraman, Ramalingam Lalitha, K. V. Raja, Naga Mallikarjuna Routhu, Hari Babu |
author_facet | Peraman, Ramalingam Lalitha, K. V. Raja, Naga Mallikarjuna Routhu, Hari Babu |
author_sort | Peraman, Ramalingam |
collection | PubMed |
description | In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH was adjusted to 3.1. The flow rate was 1 mLmin(−1) and the photodiode array detection wavelength was 254 nm. Forced degradation of the drug was carried out under acidic, basic, thermal, photolytic, peroxide, and neutral conditions. Chromatographic peak purity data indicated no co-eluting peaks with the main peaks. This method resulted in the detection of seven degradation products (D1–D7). Among these, three major degradation products from acidic and basic hydrolysis were identified and characterized by (1)H-NMR, (13)C-NMR, and mass spectral data. The method was validated as per International Conference on Harmonization guidelines (Q2). The linearity of the method was in the concentration range of 20–120 μgmL(−1). The relative standard deviations for intra- and interday precision were below 1.5%. The specificity of the method is suitable for the stability-indicating assay. |
format | Online Article Text |
id | pubmed-4065123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Österreichische Apotheker-Verlagsgesellschaft |
record_format | MEDLINE/PubMed |
spelling | pubmed-40651232014-06-23 Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms Peraman, Ramalingam Lalitha, K. V. Raja, Naga Mallikarjuna Routhu, Hari Babu Sci Pharm Research Article In this stability-indicating, reversed-phase high-performance liquid chromatographic method for flupiritine maleate, forced degradation has been employed and the formed degradants were separated on a C(18) column with a 80:20% v/v mixture of methanol-water containing 0.2% (v/v) triethylamine; the pH was adjusted to 3.1. The flow rate was 1 mLmin(−1) and the photodiode array detection wavelength was 254 nm. Forced degradation of the drug was carried out under acidic, basic, thermal, photolytic, peroxide, and neutral conditions. Chromatographic peak purity data indicated no co-eluting peaks with the main peaks. This method resulted in the detection of seven degradation products (D1–D7). Among these, three major degradation products from acidic and basic hydrolysis were identified and characterized by (1)H-NMR, (13)C-NMR, and mass spectral data. The method was validated as per International Conference on Harmonization guidelines (Q2). The linearity of the method was in the concentration range of 20–120 μgmL(−1). The relative standard deviations for intra- and interday precision were below 1.5%. The specificity of the method is suitable for the stability-indicating assay. Österreichische Apotheker-Verlagsgesellschaft 2014 2013-12-09 /pmc/articles/PMC4065123/ /pubmed/24959399 http://dx.doi.org/10.3797/scipharm.1310-01 Text en © Peraman et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Peraman, Ramalingam Lalitha, K. V. Raja, Naga Mallikarjuna Routhu, Hari Babu Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title | Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title_full | Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title_fullStr | Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title_full_unstemmed | Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title_short | Identification of Degradation Products and a Stability-Indicating RP-HPLC Method for the Determination of Flupirtine Maleate in Pharmaceutical Dosage Forms |
title_sort | identification of degradation products and a stability-indicating rp-hplc method for the determination of flupirtine maleate in pharmaceutical dosage forms |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065123/ https://www.ncbi.nlm.nih.gov/pubmed/24959399 http://dx.doi.org/10.3797/scipharm.1310-01 |
work_keys_str_mv | AT peramanramalingam identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms AT lalithakv identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms AT rajanagamallikarjuna identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms AT routhuharibabu identificationofdegradationproductsandastabilityindicatingrphplcmethodforthedeterminationofflupirtinemaleateinpharmaceuticaldosageforms |